← Leaderboards
Pierre-Yves Desprez
California Pacific Med Ctr Res Institute
$1,786,868
Attributed
$1,786,868
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $577.9K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,786,868 · 2
By mechanism
P01$1,142,971 · 1
R01$643,897 · 1
Top collaborators
No co-investigators on record.
Most similar at California Pacific Med Ctr Res Institute
Same institution · by research overlap
- Russell T Hepple$14,589,506
Others in their field
Top investigators on “Cell Proliferation”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- David Heimbrook · Leidos Biomedical Research, Inc.$103,164,048
- Timothy J Eberlein · Washington University$49,931,668
- Deirdre R. Meldrum · University Of Washington$37,202,510
- Robert A Weinberg · Whitehead Institute For Biomedical Res$32,735,166
Research focus
Cell ProliferationAlzheimer&AposTranscription FactorLaboratory MouseNeoplasm /Cancer InvasivenessSteroid HormoneFemaleCell DifferentiationHuman TissueIn Situ HybridizationNeoplasm /Cancer GeneticsGene ExpressionNeoplastic ProcessProgesteroneMammary EpitheliumCell Growth RegulationClinical ResearchEstrogensGenetic Promoter ElementHormone Regulation /Control MechanismBreast NeoplasmsImmunocytochemistryMammary GlandAutomobile Driving
Grant awards (5)
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$565,088
P01 · FY2025 · AG · contact PI
Cellular senescence and cell fate/interactions as drivers of Alzheimer's and age-related dementias$577,883
P01 · FY2024 · AG · contact PI
ID-1 EXPRESSION IN BREAST EPITHELIAL CELLS$226,738
R01 · FY2002 · CA
ID-1 EXPRESSION IN BREAST EPITHELIAL CELLS$220,485
R01 · FY2001 · CA
ID-1 EXPRESSION IN BREAST EPITHELIAL CELLS$196,674
R01 · FY2000 · CA